Expression and Function of mARC: Roles in Lipogenesis and Metabolic Activation of Ximelagatran

• Etienne P. A. Neve,

  Affiliation Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Harald Köfeler,

  Affiliation Medical University Graz, Center for Medical Research (ZMF), Graz, Austria

  ⨯
• Delilah F. G. Hendriks,

  Affiliation Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Åsa Nordling,

  Affiliation Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Vladimir Gogvadze,

  Affiliation Institute of Environmental Medicine, Section of Toxicology, Stockholm, Sweden

  ⨯
• Souren Mkrtchian,

  Affiliation Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Erik Näslund,

  Affiliation Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Magnus Ingelman-Sundberg

  * E-mail: magnus.ingelman-sundberg@ki.se

  Affiliation Section of Pharmacogenetics, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden

  ⨯